CRISPRMED27 - The 4th CRISPR MEDiCiNE Conference 2027

Copenhagen, Denmark
April 19-22, 2027

Join the CRISPR MEDiCiNE Community in Copenhagen
April 19-22, 2027

The 4th CRISPR MEDiCiNE Conference will bring together researchers, clinicians, industry leaders, and regulators to discuss where the field is heading, and what is needed to move gene editing-based therapies safely and effectively from innovation to impact.

Expect:

  • World-class speakers from academia, biotech, and industry

  • Skill-building workshops to accelerate your career

  • Patients and patient advocates sharing perspectives on the real-world impact of CRISPR medicine

  • Satellite meetings connecting experts in IP/FTO, gene-editing and screening facilities, and regulatory bodies worldwide

  • Live on-site and virtual poster sessions to showcase your work

Satellite Meeting Highlights 2027:

  • Special Global: CRISPR Medicine in Saudi Arabia - Clinical Translation, Collaboration, and Opportunities Ahead

  • Special Global: CRISPR Medicine - Landscape and Challenges in Africa

Submit your abstract to be considered for an oral presentation, or featured in CRISPR Medicine News, read by 35,000+ professionals monthly.

Keynote Speakers

Alexis KomorUniversity of California San Diego, United States
Danny CohnUniversity of Amsterdam, Amsterdam, Netherlands

Sponsors and Supporters (early confirmed)

Aldevron
LGC Axolabs
BioSpring GmbH
IDT
ST Pharm

Important Dates before the Event

  • July 1st 2026: Early bird registration & abstract submissions open

  • December 7th 2026: Early bird registration deadline 

  • January 12th 2027: Abstract submission deadline

  • February 2027: Oral and poster notifications

  • March 2027: Final CRISPRMED27 programme available / Travel grant notification

  • April 3rd 2027: Registration deadline (In-person Event)

  • April 10th 2027: Registration deadline (Virtual Event)

  • April 13th 2027: Abstract publication in the CRISPR Medicine News portal

Events at CRISPRMED27 Hybrid (preliminary)

All presentations from the Scientific Conference will be recorded and available after the conference to all registrants.

NB: Satellite meetings and workshops will NOT be recorded or available virtually.

Why Attend CRISPRMED27?

  • Stay at the Cutting Edge - The latest on CRISPR tools, functional genomics, delivery strategies, in vivo editing, clinical progress, and AI-driven therapeutic development.

  • Learn from Global Leaders - Direct access to top researchers, clinicians, biotech innovators, regulators, and patient advocates shaping the future of genomic medicine.

  • From Bench to Bedside - See how CRISPR and other gene-editing technologies translate into real therapies, and navigate CMC, pre-clinical, and clinical pathways with expert guidance.

  • Advance Your Career - Technical workshops, communication challenges, and poster sessions designed to move you forward professionally.

  • Connect and Collaborate - 400+ participants, flash talks, satellite meetings, and founders' circles built for meaningful collaboration.

  • Hybrid, Your Way - Interactive panels, social events, and virtual sessions so you can engage fully whether you're in Copenhagen or joining remotely.

Invited Speakers

Anastasia ContiSan Raffaele Telethon Institute for Gene Therapy (SR-TIGET), Italy
Alessia CavazzaUniversity College London, UK & Università Modena Reggio-Emilia, Italy
André CohnenBayer Pharmaceuticals, Germany
Brad RingeisenInnovative Genomics Institute, University of California, Berkeley, United States
Daniël WarmerdamAmsterdam UMC, Netherlands
Cecilia Jiménez-MallebreraInstitut de Recerca Sant Joan de Déu, Spain
Jakob NilssonDanish Cancer Institute, Denmark
Julian GrünewaldTechnical University of Munich, Germany
Marcello MarescaAstraZeneca, Denmark
Marianne CarlonKU Leuven, Belgium
Mario AmendolaGenethon, France
Michael OttHannover Medical School, Germany
Michela MilaniSan Raffaele Telethon Institute for Gene Therapy (SR-Tiget), Italy
Stephan KadaukeChildren's Hospital of Philadelphia, United States
Özcan MetNational Center for Cancer Immune Therapy, Herlev Hospital, Denmark
Toni CathomenITG Medical Center, Freiburg, Germany
CRISPRMED Emerging Innovator Fellowship 2027

The CRISPRMED Emerging Innovator Fellowship 2027 will be awarded live on stage at CRISPRMED27. This award celebrates one young researcher whose groundbreaking work exemplifies the future of gene-editing therapeutics.

Industry Speakers (early confirmed)

Speaker tbaAldevron
Speaker tbaAtrandi BioSciences
Speaker tbaBiospring
Speaker tbaBroken String Biosciences
Speaker tbaIntegrated DNA Technologies, IDT
Speaker tbaST Pharm

Questions? Check out our FAQ section or contact CRISPRMED27 staff at info@crisprmedicineconference.com.

Want to be updated on CRISPRMED27 latest news?

Scientific Committee

  • André Cohnen, VP, Head of Genomic Medicine at Bayer Pharmaceuticals, Germany.

  • Anastasia Conti, Project Leader, San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), Italy.

  • Cecilia Jimenez-Mallebrera, PhD and Research Director, Institut de Recerca Sant Joan de Déu, Hospital Sant Joan de Déu Barcelona and CIBERER, Spain.

  • Daniël Warmerdam, Assistant Professor of Molecular Therapy Development, Emma Center for Personalized Medicine, Department of Human Genetics, Amsterdam UMC, Netherlands.

  • Jakob Nilsson, Professor and Group Leader, Danish Cancer Institute, Denmark.

  • Julian Grünewald, Assistant Professor of Gene Editing, Technical University of Munich, Germany.

  • Karen O'Hanlon Cohrt, Data Intelligence and Infrastructure Manager, CRISPR Medicine News.

Organising Committee

Location

Hybrid event:

Copenhagen, Denmark

Copenhagen

Denmark

Dates

Registration period:

July 1, 2026 - 12:00 AM CEST - April 21, 2027 - 11:59 PM CEST

Contact us

If you have any questions, please contact info@crisprmedicineconference.com